A once hidden (and probably destined to be hidden again)
document from the FDA justifying the safe usage of Hydroxychloroquine (HCQ) as
an effective treatment against COVID-19 is exposed by the journalists at The National Pulse. What is
more heinously shocking is the reason the FDA buried HCQ good news! After
reading the FDA/HCQ
exposé, I’m providing a list of source substantiating HCQ usage science to co-opt HCQ liars at the end of The National Post article.
exposé, I’m providing a list of source substantiating HCQ usage science to co-opt HCQ liars at the end of The National Post article.
JRH 8/5/20
Your generosity is always appreciated - various credit,
check
& debit cards are accepted by my PayPal
account:
Or support by getting in
the Coffee from home business –
OR just buy some
FEEL GOOD coffee, that includes immune boosting products.
*******************************
EXCLUSIVE: Hidden FDA Doc Explains Why “Liar” Fauci
Opposes Hydroxychloroquine, Top Doctors Explain
By Staff Writer
August 4, 2020
A document no longer available from the U.S. Food and
Drug Administration regarding “Emergency Use Authorization” of potential
COVID-19 treatments appears to suggest that hydroxychloroquine satisfies the
criteria for the classification, but would stand in the way of lucrative other
drugs, and a vaccine.
The possible treatment, shunned by the mainstream media and Big Tech, has
far-ranging champions from Yale epidemiologists
to frontline doctors to President Trump.
Despite this support, corroborated by
scientific studies, the medical establishment under the auspices of Dr. Anthony
Fauci have refused to grant hydroxychloroquine “Emergency Use Authorization”
(EUA).
July 29th documents from a Food and Drug Administration
(FDA) presentation reveal, however, that the “qualifying criteria” for
extending EUA to the drug appear to have been met: it “may be effective” and
that “no adequate, approved, and available alternative” exists.
The document makes clear that Emergency Use Authorization
cannot be used for more than one drug or therapeutic, and the establishment is
potentially therefore saving the EUA pre-emptively for vaccines and remdesivir
– patently high-value Big Pharma drugs – instead of hydroxychloroquine.
Dr. Vladimir Zelenko, who authored a study
on the efficacy of hydroxychloroquine, outlined the medical establishment’s
campaign against the drug on the War Room: Pandemic show.
He emphasized that Dr. Fauci has “lied to the American
people” by insisting that authorizing a treatment for COVID-19 rests on
“controlled trials to get anything through the FDA.”
“That is not true. That has never been the historical
precedent and almost no other medication has ever had to meet those standards,”
Dr. Zelenko continued.
He also noted that due to the sheer existence of
hydroxychloroquine – a potential treatment – “available drugs like Remdesevir
and the vaccine by [the FDA’s] own internal rules cannot get EUA.”
Such a classification would “facilitate the availability and use”
of the drug and represents a fast-track alternative to authorizing potential
life-saving treatments during public health emergencies such as the ongoing
pandemic.
THE DOCUMENT IN FULL: https://www.docdroid.net/Ispn8Ym/fink-fda-eua-licensing-slides-2020-pdf
[Blog Editor: In case some kind of crazy censorship
renders the PDF link void, I downloaded it. If that happens leave email asking
for the PDF in the comment section and I will email it to you. For privacy
purposes all comments need approval to be posted. I will not post your email.]
Or, as Dr. Zelenko describes, “there’ 150,000 dead corpses,
most of which could have been avoided if Dr. Fauci did the moral and correct
thing.”
The eight-page presentation entitled “Considerations for FDA
Licensure vs. Emergency Use Authorization of COVID-19 Vaccines” posits two
additional prerequisites for EUA: “declaration by HHS Secretary of emergency
situation leading to serious or life-threatening disease or condition,” which occurred
in January, and that
the “known and potential benefits of the product outweigh the known and
potential risks of the product.”
__________________________________
Edited by Raheem Kassam
The National Pulse SUPPORT
PAGE
++++++++++++++++++
Actual science indicating HCQ not perfect but safe. All
drugs have the potential for side effects. The Doctor/Patient has to weigh the
drug for what is known of patient reactions on a personal basis. The science
shows in MOST cases (long before COVID) HCQ designed for malaria has been
helpful for other maladies for decades:
Lancet HCQ criticism refuted: https://www.webmd.com/lung/news/20200603/study-on-hydroxychloroquine-for-covid-questioned
Hydroxychloroquine is a Food & Drug
Administration (FDA)-approved drug for the long-term treatment and prevention
of autoimmune conditions like rheumatoid arthritis and systemic lupus. It’s a
disease-modifying anti-rheumatic drug (DMARD) that decreases the swelling and
pain caused by arthritis. It’s also prescribed for the treatment and prevention
of acute attacks of malaria. Hydroxychloroquine is available in the US by
prescriptions only. It’s sold both as a brand name and a generic version: https://www.rx2go.com/buy/hydroxychloroquine/
The progression of RA may be diminished in severity and
duration by the combination of medicines and therapy that work best as
determined by you and your physician. You can also put off joint damage,
and in some cases, you can do more than just slow it down. Being able to
stop joint damage can lessen pain and mean a better quality of life.
Hydroxychloroquine is one of the medications that can be a valuable part
of your treatment plan: https://www.rheumatoidarthritis.org/treatment/hydroxychloroquine/
Hydroxychloroquine and chloroquine are medications that
have been used for a long time. Their most common use is for the treatment and
prophylaxis of malaria. However, these antimalarial drugs are known to also
have anti-inflammatory and antiviral effects and are used for several chronic
diseases such as systemic lupus erythematosus with low adverse effects. The antiviral
action of hydroxychloroquine and chloroquine has been a point of interest to
different researchers due to its mechanism of action. Several in vitro studies
have proven their effectiveness on severe acute respiratory syndrome virus and
currently both in vitro and in vivo studies have been conducted on 2019 novel
coronavirus (covid-19). The purpose of this article is to review the history
and mechanism of actions of these drugs and the potential use they can have on
the current covid-19 pandemic. …: https://pmj.bmj.com/content/early/2020/05/28/postgradmedj-2020-137785
No comments:
Post a Comment